Literature DB >> 2677235

Infection of brain cells by diverse human immunodeficiency virus isolates: role of CD4 as receptor.

J Weber1, P Clapham, J McKeating, M Stratton, E Robey, R Weiss.   

Abstract

Cell lines originally derived from malignant tumours of the brain were infected by diverse human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) isolates. By surface immunofluorescence it was shown that susceptible cells did not bear the CD4 antigen. They were also non-permissive for the formation of plaques by vesicular stomatitis virus pseudotypes and did not form syncytia with HIV-producing cells. Virus production was of low titre, and reverse transcriptase and the p24 antigen were consistently undetectable in the culture supernatants. Output virus could be detected by cocultivation with a sensitive T cell line, C8166, by the culture of supernatant medium with T cells and by detection of proviral HIV DNA after amplification. A higher multiplicity of input virus was required to establish a brain cell infection than was required for T lymphocytes or monocytes. Some HIV-susceptible brain cells contained mRNA for CD4 but infection was not blocked by anti-CD4 antibodies. Apparently HIV infection of these cells does not involve CD4 as the cellular receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2677235     DOI: 10.1099/0022-1317-70-10-2653

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Sequence homology between HIV gp120, rabies virus glycoprotein, and snake venom neurotoxins. Is the nicotinic acetylcholine receptor an HIV receptor?

Authors:  P Neri; L Bracci; M Rustici; A Santucci
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4.

Authors:  P R Clapham; A McKnight; R A Weiss
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.

Authors:  Jijin Gu; Karam Al-Bayati; Emmanuel A Ho
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

4.  In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.

Authors:  J Chehimi; S Bandyopadhyay; K Prakash; B Perussia; N F Hassan; H Kawashima; D Campbell; J Kornbluth; S E Starr
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism.

Authors:  A V Moses; F E Bloom; C D Pauza; J A Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

Review 6.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

7.  Effects of human immunodeficiency virus encephalitis and drug abuse on the B lymphocyte population of the brain.

Authors:  Iain C Anthony; Dorothy H Crawford; Jeanne E Bell
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

8.  Replicative difference in early-passage feline brain cells among feline immunodeficiency virus isolates.

Authors:  Y Kawaguchi; K Maeda; Y Tohya; T Furuya; T Miyazawa; T Horimoto; J Norimine; C Kai; T Mikami
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences.

Authors:  B T Korber; K J Kunstman; B K Patterson; M Furtado; M M McEvilly; R Levy; S M Wolinsky
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

10.  Deoxyglucose uptake by mouse astrocytes: effects of temperature and retrovirus infection.

Authors:  J M Vann; A J Goldman; P F Szurek; B R Brooks
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.